UW Today

Initial positive results reported on vaccine to treat genital herpes

The vaccine is the first to significantly reduce the frequency of viral shedding — the surfacing of herpes virus on the genitals — and appears to activate T cell immune responses to the virus.

Functional genomics lab to predict potential AIDS vaccines efficacy and find protection markers

Funded by the NIH at $15 million over five years, the lab will be a national resource to evaluate candidate vaccines from studies around the country.